Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes

A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2010-06, Vol.18 (12), p.4498-4508
Hauptverfasser: Dallanoce, Clelia, Frigerio, Fabio, Martelli, Giuliana, Grazioso, Giovanni, Matera, Carlo, Pomè, Diego Yuri, Pucci, Luca, Clementi, Francesco, Gotti, Cecilia, De Amici, Marco
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4508
container_issue 12
container_start_page 4498
container_title Bioorganic & medicinal chemistry
container_volume 18
creator Dallanoce, Clelia
Frigerio, Fabio
Martelli, Giuliana
Grazioso, Giovanni
Matera, Carlo
Pomè, Diego Yuri
Pucci, Luca
Clementi, Francesco
Gotti, Cecilia
De Amici, Marco
description A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed at alpha4beta2 and alpha7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the alpha4beta2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the alpha7 subtype. The binding mode of the bromo-Delta(2)-isoxazolines 4b and 7b, which were the highest affinity ligands in the series (K(i)=0.92 and 0.75 microM, respectively), was analyzed by applying a recently developed model of the alpha4beta2 nAChRs.
doi_str_mv 10.1016/j.bmc.2010.04.065
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733404700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733404700</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-43f53adee334c5ec7de7a54877ea303c3836cb20ea5b8b3c2886b6ca5bbeaf6b3</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0kREvhA9gg74BFgh95lR0qT6mCDawj25lQV44dYqdq-CF-kwBFrEZ35sy90kXohJKYEppdrmPZqJiRUZMkJlm6h6Y0yZKI8zmdoEPv14QQlszpAZowkuRFTskUfT65DRgcOq0GZbTCN2CCOGcXkfZuKz6c0RawsBXmkdu6iEUNhNVg_s_VN1BBpzci6A34K-wHG1bgtf_5k9qOyBsWda2tDgMWAVvoO2eFwVYrF8a1wkJBGIxa_QZ2oKANrsO-l2FowR-h_VoYD8e7OUOvd7cvi4do-Xz_uLheRi2jJEQJr1MuKgDOE5WCyivIRZoUeQ6CE654wTMlGQGRykJyxYoik5kalQRRZ5LP0Nmvb9u59x58KBvtFRgjLLjel_loPJZHyEie7sheNlCVbacb0Q3lX7f8C-c7f-U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733404700</pqid></control><display><type>article</type><title>Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Dallanoce, Clelia ; Frigerio, Fabio ; Martelli, Giuliana ; Grazioso, Giovanni ; Matera, Carlo ; Pomè, Diego Yuri ; Pucci, Luca ; Clementi, Francesco ; Gotti, Cecilia ; De Amici, Marco</creator><creatorcontrib>Dallanoce, Clelia ; Frigerio, Fabio ; Martelli, Giuliana ; Grazioso, Giovanni ; Matera, Carlo ; Pomè, Diego Yuri ; Pucci, Luca ; Clementi, Francesco ; Gotti, Cecilia ; De Amici, Marco</creatorcontrib><description>A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed at alpha4beta2 and alpha7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the alpha4beta2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the alpha7 subtype. The binding mode of the bromo-Delta(2)-isoxazolines 4b and 7b, which were the highest affinity ligands in the series (K(i)=0.92 and 0.75 microM, respectively), was analyzed by applying a recently developed model of the alpha4beta2 nAChRs.</description><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2010.04.065</identifier><identifier>PMID: 20478710</identifier><language>eng</language><publisher>England</publisher><subject>Alkaloids - chemistry ; alpha7 Nicotinic Acetylcholine Receptor ; Animals ; Azocines - chemistry ; Binding Sites ; Bridged Bicyclo Compounds, Heterocyclic - chemistry ; Heterocyclic Compounds, 3-Ring - chemical synthesis ; Heterocyclic Compounds, 3-Ring - chemistry ; Heterocyclic Compounds, 3-Ring - pharmacology ; Isoxazoles - chemical synthesis ; Isoxazoles - chemistry ; Isoxazoles - pharmacology ; Ligands ; Models, Molecular ; Neurons - metabolism ; Protein Binding ; Quinolizines - chemistry ; Rats ; Receptors, Nicotinic - chemistry ; Receptors, Nicotinic - metabolism</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2010-06, Vol.18 (12), p.4498-4508</ispartof><rights>Copyright 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20478710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dallanoce, Clelia</creatorcontrib><creatorcontrib>Frigerio, Fabio</creatorcontrib><creatorcontrib>Martelli, Giuliana</creatorcontrib><creatorcontrib>Grazioso, Giovanni</creatorcontrib><creatorcontrib>Matera, Carlo</creatorcontrib><creatorcontrib>Pomè, Diego Yuri</creatorcontrib><creatorcontrib>Pucci, Luca</creatorcontrib><creatorcontrib>Clementi, Francesco</creatorcontrib><creatorcontrib>Gotti, Cecilia</creatorcontrib><creatorcontrib>De Amici, Marco</creatorcontrib><title>Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed at alpha4beta2 and alpha7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the alpha4beta2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the alpha7 subtype. The binding mode of the bromo-Delta(2)-isoxazolines 4b and 7b, which were the highest affinity ligands in the series (K(i)=0.92 and 0.75 microM, respectively), was analyzed by applying a recently developed model of the alpha4beta2 nAChRs.</description><subject>Alkaloids - chemistry</subject><subject>alpha7 Nicotinic Acetylcholine Receptor</subject><subject>Animals</subject><subject>Azocines - chemistry</subject><subject>Binding Sites</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - chemistry</subject><subject>Heterocyclic Compounds, 3-Ring - chemical synthesis</subject><subject>Heterocyclic Compounds, 3-Ring - chemistry</subject><subject>Heterocyclic Compounds, 3-Ring - pharmacology</subject><subject>Isoxazoles - chemical synthesis</subject><subject>Isoxazoles - chemistry</subject><subject>Isoxazoles - pharmacology</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>Neurons - metabolism</subject><subject>Protein Binding</subject><subject>Quinolizines - chemistry</subject><subject>Rats</subject><subject>Receptors, Nicotinic - chemistry</subject><subject>Receptors, Nicotinic - metabolism</subject><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAQRS0kREvhA9gg74BFgh95lR0qT6mCDawj25lQV44dYqdq-CF-kwBFrEZ35sy90kXohJKYEppdrmPZqJiRUZMkJlm6h6Y0yZKI8zmdoEPv14QQlszpAZowkuRFTskUfT65DRgcOq0GZbTCN2CCOGcXkfZuKz6c0RawsBXmkdu6iEUNhNVg_s_VN1BBpzci6A34K-wHG1bgtf_5k9qOyBsWda2tDgMWAVvoO2eFwVYrF8a1wkJBGIxa_QZ2oKANrsO-l2FowR-h_VoYD8e7OUOvd7cvi4do-Xz_uLheRi2jJEQJr1MuKgDOE5WCyivIRZoUeQ6CE654wTMlGQGRykJyxYoik5kalQRRZ5LP0Nmvb9u59x58KBvtFRgjLLjel_loPJZHyEie7sheNlCVbacb0Q3lX7f8C-c7f-U</recordid><startdate>20100615</startdate><enddate>20100615</enddate><creator>Dallanoce, Clelia</creator><creator>Frigerio, Fabio</creator><creator>Martelli, Giuliana</creator><creator>Grazioso, Giovanni</creator><creator>Matera, Carlo</creator><creator>Pomè, Diego Yuri</creator><creator>Pucci, Luca</creator><creator>Clementi, Francesco</creator><creator>Gotti, Cecilia</creator><creator>De Amici, Marco</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20100615</creationdate><title>Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes</title><author>Dallanoce, Clelia ; Frigerio, Fabio ; Martelli, Giuliana ; Grazioso, Giovanni ; Matera, Carlo ; Pomè, Diego Yuri ; Pucci, Luca ; Clementi, Francesco ; Gotti, Cecilia ; De Amici, Marco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-43f53adee334c5ec7de7a54877ea303c3836cb20ea5b8b3c2886b6ca5bbeaf6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alkaloids - chemistry</topic><topic>alpha7 Nicotinic Acetylcholine Receptor</topic><topic>Animals</topic><topic>Azocines - chemistry</topic><topic>Binding Sites</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - chemistry</topic><topic>Heterocyclic Compounds, 3-Ring - chemical synthesis</topic><topic>Heterocyclic Compounds, 3-Ring - chemistry</topic><topic>Heterocyclic Compounds, 3-Ring - pharmacology</topic><topic>Isoxazoles - chemical synthesis</topic><topic>Isoxazoles - chemistry</topic><topic>Isoxazoles - pharmacology</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>Neurons - metabolism</topic><topic>Protein Binding</topic><topic>Quinolizines - chemistry</topic><topic>Rats</topic><topic>Receptors, Nicotinic - chemistry</topic><topic>Receptors, Nicotinic - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dallanoce, Clelia</creatorcontrib><creatorcontrib>Frigerio, Fabio</creatorcontrib><creatorcontrib>Martelli, Giuliana</creatorcontrib><creatorcontrib>Grazioso, Giovanni</creatorcontrib><creatorcontrib>Matera, Carlo</creatorcontrib><creatorcontrib>Pomè, Diego Yuri</creatorcontrib><creatorcontrib>Pucci, Luca</creatorcontrib><creatorcontrib>Clementi, Francesco</creatorcontrib><creatorcontrib>Gotti, Cecilia</creatorcontrib><creatorcontrib>De Amici, Marco</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dallanoce, Clelia</au><au>Frigerio, Fabio</au><au>Martelli, Giuliana</au><au>Grazioso, Giovanni</au><au>Matera, Carlo</au><au>Pomè, Diego Yuri</au><au>Pucci, Luca</au><au>Clementi, Francesco</au><au>Gotti, Cecilia</au><au>De Amici, Marco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2010-06-15</date><risdate>2010</risdate><volume>18</volume><issue>12</issue><spage>4498</spage><epage>4508</epage><pages>4498-4508</pages><eissn>1464-3391</eissn><abstract>A group of novel tricyclic Delta(2)-isoxazolines (4b, 5b, 7a-b, and 8a-b) and 3-oxo-isoxazolidines (6a-b and 9a-b), structurally related to cytisine or norferruginine, was prepared through 1,3-dipolar cycloadditions involving suitable olefins and bromonitrile oxide. The target compounds were assayed at alpha4beta2 and alpha7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the alpha4beta2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the alpha7 subtype. The binding mode of the bromo-Delta(2)-isoxazolines 4b and 7b, which were the highest affinity ligands in the series (K(i)=0.92 and 0.75 microM, respectively), was analyzed by applying a recently developed model of the alpha4beta2 nAChRs.</abstract><cop>England</cop><pmid>20478710</pmid><doi>10.1016/j.bmc.2010.04.065</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1464-3391
ispartof Bioorganic & medicinal chemistry, 2010-06, Vol.18 (12), p.4498-4508
issn 1464-3391
language eng
recordid cdi_proquest_miscellaneous_733404700
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Alkaloids - chemistry
alpha7 Nicotinic Acetylcholine Receptor
Animals
Azocines - chemistry
Binding Sites
Bridged Bicyclo Compounds, Heterocyclic - chemistry
Heterocyclic Compounds, 3-Ring - chemical synthesis
Heterocyclic Compounds, 3-Ring - chemistry
Heterocyclic Compounds, 3-Ring - pharmacology
Isoxazoles - chemical synthesis
Isoxazoles - chemistry
Isoxazoles - pharmacology
Ligands
Models, Molecular
Neurons - metabolism
Protein Binding
Quinolizines - chemistry
Rats
Receptors, Nicotinic - chemistry
Receptors, Nicotinic - metabolism
title Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20tricyclic%20Delta(2)-isoxazoline%20and%203-oxo-2-methyl-isoxazolidine%20derivatives:%20synthesis%20and%20binding%20affinity%20at%20neuronal%20nicotinic%20acetylcholine%20receptor%20subtypes&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Dallanoce,%20Clelia&rft.date=2010-06-15&rft.volume=18&rft.issue=12&rft.spage=4498&rft.epage=4508&rft.pages=4498-4508&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2010.04.065&rft_dat=%3Cproquest_pubme%3E733404700%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733404700&rft_id=info:pmid/20478710&rfr_iscdi=true